These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 768428)

  • 1. [Bioassay in the medical treatment of the inner ear diseases (author's transl)].
    Morimitsu T; Matsumoto I; Hayashida K
    Nihon Jibiinkoka Gakkai Kaiho; 1975 Dec; 78(12):1271-7. PubMed ID: 768428
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of vestibular and cochlear disorders using meclofenoxate].
    Skovronský O; Vanecek M
    Cesk Otolaryngol; 1978 Aug; 27(4):235-9. PubMed ID: 361264
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of acute inner ear diseases (sudden deafness and vestibular disorder) with meclofenoxate and acetylsalicylic acid].
    Weinaug P
    HNO; 1988 Jun; 36(6):226-9. PubMed ID: 3137190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cetrexin and its effect on the psychic condition of postprostatectomy patients (author's transl)].
    Bocková E; Polácková J; Toufarová P
    Cas Lek Cesk; 1981 Aug; 120(33):998-1000. PubMed ID: 6794914
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the effect of centrophenoxine for the lipofuscin in the nerve cells of the aged guinea pigs (author's transl)].
    Tomonaga M; Izumiyama N; Kameyama M
    Nihon Ronen Igakkai Zasshi; 1978 Jul; 15(4):355-61. PubMed ID: 362027
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of Cerutil (centrophenoxine) in patients with cerebral sclerosis].
    Schilter R
    Z Alternsforsch; 1974; 28(3):231-8. PubMed ID: 4619249
    [No Abstract]   [Full Text] [Related]  

  • 7. Antianoxic effect of meclofenoxate related to its disposition.
    Miyazaki H; Nambu K; Hashimoto M
    Chem Pharm Bull (Tokyo); 1976 Apr; 24(4):822-5. PubMed ID: 779990
    [No Abstract]   [Full Text] [Related]  

  • 8. [Meclofenoxate in acute drepanocytic crises].
    Le Bras M; Coirault R; Bouchez P; Bertrand E
    Nouv Presse Med; 1976 Apr; 6(17):1478-9. PubMed ID: 799777
    [No Abstract]   [Full Text] [Related]  

  • 9. [The apoplexy of the labyrinth (author's transl)].
    Ritter K; Veit C
    Laryngol Rhinol Otol (Stuttg); 1977 Apr; 56(4):346-50. PubMed ID: 140982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The differential effects of meclofenoxate on memory loss in the elderly.
    Marcer D; Hopkins SM
    Age Ageing; 1977 May; 6(2):123-31. PubMed ID: 329662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meclofenoxate therapy in tardive dyskinesia: a preliminary report.
    Izumi K; Tominaga H; Koja T; Nomoto M; Shimizu T; Sonoda H; Imamura K; Igata A; Fukuda T
    Biol Psychiatry; 1986 Feb; 21(2):151-60. PubMed ID: 2868761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of drugs on the postictal coma prolonged by repeated electroshocks in mice (author's transl)].
    Fukuda T; Araki Y
    Fukuoka Igaku Zasshi; 1974 Jun; 65(6):363-6. PubMed ID: 4613638
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectivity of Cavinton and Lucidril in the treatment of hearing defects of different origin.
    Jasper A
    Ther Hung; 1979; 27(1):29-31. PubMed ID: 386551
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effectiveness and tolerance of Helfergia granules in children].
    Held F
    Med Welt; 1979 May; 30(21):835-6. PubMed ID: 374928
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of lucidril on the metabolism of some animal tissues in vitro. Comparison with the effect of heminevrin (author's transl)].
    Pogády J; Orlický J; Ruscák M
    Bratisl Lek Listy; 1978 Apr; 69(4):427-32. PubMed ID: 346176
    [No Abstract]   [Full Text] [Related]  

  • 16. [Unpublished pharmacological aspects of meclofenoxate (centrophenoxine)].
    Llenas J; Bargalló MA; Bermejo P; Giráldez A; Bruseghini L
    Arch Farmacol Toxicol; 1978 Apr; 4(1):128-31. PubMed ID: 358925
    [No Abstract]   [Full Text] [Related]  

  • 17. [The activity and capacity of the inner ear (author's transl)].
    Lotz P; Kuhl KD
    Laryngol Rhinol Otol (Stuttg); 1976 Dec; 55(12):1002-5. PubMed ID: 138030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Double-blind collaborative study of centrophenoxine versus placebo in patients with neurasthenic syndromes].
    Pieschl D; Angersbach P; Kolbe M; Toman M
    Nervenarzt; 1983 Jan; 54(1):48-53. PubMed ID: 6405290
    [No Abstract]   [Full Text] [Related]  

  • 19. Immediate effects of neurodynamic substances on verbal performance in the treatment of aphasia.
    Gheorghiţă N
    Neurol Psychiatr (Bucur); 1977; 15(2):95-101. PubMed ID: 329396
    [No Abstract]   [Full Text] [Related]  

  • 20. Inability to deactivate the sympathetic nervous system in patients with brainstem infarction; correction of the disorder by centrophenoxine administration.
    Stoica E; Enulescu O; Nicolae A
    Neurol Psychiatr (Bucur); 1983; 21(4):425-39. PubMed ID: 6419342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.